S Yamagishi, T Imaizumi - Current pharmaceutical design, 2005 - ingentaconnect.com Abstract: Diabetic vascular complication is a leading cause of end-stage renal failure, acquired
blindness, a variety of neuropathies and accelerated atherosclerosis, which could account for
disabilities and high mortality ... Cited by 123 - Related articles - All 3 versions
- ►nih.gov K Abeyama, DM Stern, Y Ito, K Kawahara, … - Journal of Clinical …, 2005 - Am Soc Clin Investig 1 Department of Laboratory and Molecular Medicine and 2 Department of Preventive Medicine, Shin
Nippon Biomedical Laboratories Inc. (SNBL), Kagoshima University, Kagoshima, Japan. 3 School of
Medicine, Medical College of ... Cited by 109 - Related articles - All 10 versions
- ►physiology.org [PDF] JM Bohlender, S Franke, G Stein, G … - American Journal of …, 2005 - Am Physiological Soc 173 articles, 82 of which you can access free at: This article cites http://ajprenal.physiology.org/
cgi/content/full/289/4/F645#BIBL ... 11 other HighWire hosted articles, the first 5 are: This
article has been cited by Cited by 82 - Related articles - BL Direct - All 7 versions
- ►physiology.org I Kusaka, G Kusaka, C Zhou, M Ishikawa, … - American Journal of …, 2004 - Am Physiological Soc The objective of the present study was to examine the role of the angiotensin II type 1 receptor (AT
1 -R) in the diabetes-aggravated oxidative stress and brain injury observed in a rat model of
combined diabetes and focal ... Cited by 48 - Related articles - BL Direct - All 3 versions
L Lue, SD Yan, DM Stern, DG Walker - Current Drug Targets-CNS …, 2005 - ingentaconnect.com 1 Laboratory of Neurovascular Inflammation, Sun Health Research Institute, Sun City, AZ 85351, USA 2
College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA 3 Medical College
of Georgia, Augusta, Georgia 30912, ... Cited by 49 - Related articles - All 3 versions
- ►ahajournals.org S Sahar, RS Dwarakanath, MA Reddy, L Lanting, I … - Circulation …, 2005 - Am Heart Assoc Vascular smooth muscle cells (VSMCs) express functional interleukin-18 receptors (IL-18Rs), composed
of and ß subunits. These subunits are elevated in VSMCs of atherosclerotic plaques and can be
induced by inflammatory agents in ... Cited by 43 - Related articles - All 10 versions
- ►oxfordjournals.org L Gu, S Hagiwara, Q Fan, M Tanimoto, M Kobata, … - Nephrology Dialysis …, 2006 - ERA-EDTA Background. Upregulation of local monocyte chemoattractant protein-1 (MCP-1) production is involved
in glomerular damage through macrophage recruitment and activation in diabetic nephropathy.
Treatment of db/db mice with ... Cited by 40 - Related articles - BL Direct - All 5 versions
- ►asnjournals.org MC Thomas, C Tikellis, WM Burns, K … - Journal of the American …, 2005 - Am Soc Nephrol Although hemodynamic and metabolic factors are individually implicated in the development of
diabetic nephropathy, their interaction has not been defined clearly. In this study, the effects of
angiotensin II (Ang II) and ... Cited by 42 - Related articles - BL Direct - All 6 versions
- ►endojournals.org AM Vincent, L Perrone, KA Sullivan, C Backus, AM … - Endocrinology, 2007 - Endocrine Soc The receptor for advanced glycation end products (RAGE) may promote diabetic vascular and renal
disease through the activation of intracellular signaling pathways that promote oxidative stress.
Oxidative stress is a mediator of ... Cited by 39 - Related articles - BL Direct - All 6 versions
- ►jbc.org MA Reddy, SL Li, S Sahar, YS Kim, ZG Xu, L … - Journal of Biological …, 2006 - ASBMB The receptor for advanced glycation end products (RAGE) and its ligands have been implicated in the
activation of oxidant stress and inflammatory pathways in vascular smooth muscle cells (VSMCs)
leading to the initiation and ... Cited by 40 - Related articles - All 5 versions
